A Randomized Controlled Trial Evaluating the Efficacy of Intralesional Triamcinolone in Hidradenitis Suppurativa.
Status:
Completed
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
Purpose: To evaluate the effectiveness of intralesional triamcinolone for the treatment of
hidradenitis suppurativa (HS)
Participants: Patients diagnosed with Hidradenitis Suppurativa that have active inflammatory
HS lesions. Up to 60 lesions will be treated. Between 20 and 60 patients will be enrolled
dependent on the number of lesions they have treated. (up to 3 per patient)
Procedures (methods): Injection of triamcinolone or placebo into active lesions of
hidradenitis suppurativa